Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia

Annals of Hematology

Volumn 81, Issue 9, 2002, Pages 504-507

  Thomas, X ^a   Le, Q H ^a   Fiere, D ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Acute promyelocytic leukemia; Anthracyclines; Congestive heart failure; Prognosis

Indexed keywords

AMSACRINE; ANGIOTENSIN ANTAGONIST; ANTHRACYCLINE; BUSULFAN; CARDIAC GLYCOSIDE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; DIURETIC AGENT; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; RETINOIC ACID;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CASE REPORT; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; FEMALE; GRAFT VERSUS HOST REACTION; HEART TRANSPLANTATION; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROPHYLAXIS; TREATMENT OUTCOME;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FATAL OUTCOME; FEMALE; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MIDDLE AGED; RISK FACTORS; SURVIVORS; TREATMENT OUTCOME;

EID: 0036938433     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0534-8     Document Type: Article

References (17)

1. Alexander J, Dainish N, Berger HJ, Goldman L, Johnston D, Reduto L, Duffy T, Schwartz P, Gottschalk A, Zaret BL (1981) Serial assessment of doxorubicin cardiotoxicity with quantitative radionucleide angiography. N Engl J Med 300:276-283
2. Archimbaud E, Thomas X, Michallet M, Jaubert J, Troncy J, Guyotat D, Fiere D (1994) Prospective genetically randomized comparison between intensive postinduction chemotherapy and bone marrow transplantation in adults with newly diagnosed acute myeloid leukemia. J Clin Oncol 12:262-267
3. Archimbaud E, Thomas X, Leblond V, Michallet M, Fenaux P, Cordonnier C, Dreyfus F, Troussard X, Jaubert J, Travade P, Troncy J, Assouline D, Fiere D (1995) Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial. J Clin Oncol 13:11-18
4. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton D, Gralnick M, Sultan C (1976) Proposals for the classification of the acute leukemias. Br J Haematol 33:451-461
5. Bernard J, Weil M, Boiron M, Jacquillat C, Flandrin G, Gemon MF (1973) Acute promyelocytic leukemia: results of treatment with daunorubicin. Blood 41:489-496
6. De Thé H, Chomienne C, Lanotte M, Degos L, Dejean A (1990) The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347:558-561
7. Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Link H, Guerci A, Duarte M, Daniel MT, Bowen D, Huebner G, Bauters F, Fegueux N, Fey M, Sanz M, Löwenberg B, Maloisel F, Auzanneau G, Sadoun A, Gardin C, Bastion Y, Ganser A, Jacky E, Dombret H, Chastang C, Degos L, and the European APL 91 Group (1993) Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia: results of a multicenter randomized trial. Blood 82:3241-3249
8. Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Makhoul PC, Travade P, Solary E, Fegueux N, Bordessoule D, Miguel JS, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L (1999) A randomized comparison of all-trans retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance chemotherapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 94:1192-1200
9. Hitchcock-Bryan S, Gerber RD, Cassidy JR, Sallan SE (1986) The impact f induction anthracycline on long-term failure-free survival in childhood acute lymphoblastic leukemia. Med Pediatr Oncol 14:211-215
10. Hu ZB, Minden MD, McCulloch EA (2000) Regulation of drug sensitivity by ribosomal protein S3a. Blood 95:1047-1055
11. Krischer JP, Epstein S, Cuthbertson DD, Goorin AM, Epstein ML, Lipshultz SE (1997) Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol 15:1544-1552
12. Lemez P, Maresova J (1996) Protective effects of cardioxane against anthracycline-induced cardiotoxicity in relapsed acute myeloid leukemias. Neoplasma 43:417-419
13. Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP (1991) Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324:808-815
14. Shan K, Lincoff M, Young JB (1996) Anthracycline-induced cardiotoxicity. Ann Intern Med 125:47-58
15. Von Hoff DD, Layard MW, Basa P, Davis HLJr, Von Hoff AL, Rozencweig M, Muggia FM (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91:710-717
16. Warrell RP, Frankel SR, Miller WHJr, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubovski A, Gabrilove J, Gordon MS, Dmitrovsky E (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N Engl J Med 324:1385-1393
17. Warrell RP, De Thé H, Degos L (1993) Acute promyelocytic leukemia. N Engl J Med 329:177-189